×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NRXP – nrx pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NRXP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/20
09:00 am
nrxp
NRx Pharmaceuticals (NRXP) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $34.00 price target on the stock.
High
Report
NRx Pharmaceuticals (NRXP) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $34.00 price target on the stock.
4/20
07:16 am
nrxp
NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality [Yahoo! Finance]
High
Report
NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality [Yahoo! Finance]
4/20
07:00 am
nrxp
NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality
High
Report
NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality
4/15
07:00 am
nrxp
NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications
Low
Report
NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications
4/13
07:00 am
nrxp
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company’s first Chief Commercial Officer
Medium
Report
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company’s first Chief Commercial Officer
4/6
07:11 am
nrxp
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx's Preservative-Free Ketamine Application [Yahoo! Finance]
Neutral
Report
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx's Preservative-Free Ketamine Application [Yahoo! Finance]
4/6
07:00 am
nrxp
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application
Neutral
Report
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application
3/30
07:15 am
nrxp
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered “Depression Thermometer” Across its Interventional Psychiatry Network [Yahoo! Finance]
Medium
Report
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered “Depression Thermometer” Across its Interventional Psychiatry Network [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/14/2025
04:32 pm
NRXP
nrx pharmaceuticals, inc.
MISS
Report
-13.2%
nrx pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/24
04:32 pm
nrxp
Form 8-K NRX Pharmaceuticals, For: Mar 23
High
Report
Form 8-K NRX Pharmaceuticals, For: Mar 23
3/23
04:31 pm
nrxp
Form 10-K NRX Pharmaceuticals, For: Dec 31
High
Report
Form 10-K NRX Pharmaceuticals, For: Dec 31
2/24
05:00 pm
nrxp
Form DEFA14A NRX Pharmaceuticals,
Low
Report
Form DEFA14A NRX Pharmaceuticals,
2/23
05:16 pm
nrxp
Form ARS NRX Pharmaceuticals, For: Dec 31
Medium
Report
Form ARS NRX Pharmaceuticals, For: Dec 31
2/23
05:01 pm
nrxp
Form DEF 14A NRX Pharmaceuticals, For: Mar 23
Medium
Report
Form DEF 14A NRX Pharmaceuticals, For: Mar 23
2/17
07:01 pm
nrxp
Form 4 NRX Pharmaceuticals, For: Jan 27 Filed by: Casper Joseph Michael
Low
Report
Form 4 NRX Pharmaceuticals, For: Jan 27 Filed by: Casper Joseph Michael
2/17
07:00 pm
nrxp
Form 3 NRX Pharmaceuticals, For: Jan 27 Filed by: Casper Joseph Michael
Low
Report
Form 3 NRX Pharmaceuticals, For: Jan 27 Filed by: Casper Joseph Michael
2/17
09:21 am
nrxp
Form 8-K NRX Pharmaceuticals, For: Feb 17
Medium
Report
Form 8-K NRX Pharmaceuticals, For: Feb 17
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: